ConductScience.org, home
Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy
API referenceFor AI assistants

Trial · NCT04661579

Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDGroup 1: Positive Parasitemia; Anti-malarial Treatment + RTS,S/AS01E Vaccine164
Overall StudySTARTEDGroup 2: No Parasitemia; Anti-malarial Prophylaxis + RTS,S/AS01E Vaccine128
Overall StudySTARTEDGroup 3: Positive Parasitemia; RTS,S/AS01E Vaccine36
Overall StudySTARTEDGroup 4: Positive Parasitemia; Anti-malarial Treatment + Rabies Vaccine164
Overall StudySTARTEDGroup 5: No Parasitemia, Anti-malarial Prophylaxis + Rabies Vaccine128
Overall StudyReceived Study VaccinationGroup 1: Positive Parasitemia; Anti-malarial Treatment + RTS,S/AS01E Vaccine160
Overall StudyReceived Study VaccinationGroup 2: No Parasitemia; Anti-malarial Prophylaxis + RTS,S/AS01E Vaccine124
Overall StudyReceived Study VaccinationGroup 3: Positive Parasitemia; RTS,S/AS01E Vaccine35
Overall StudyReceived Study VaccinationGroup 4: Positive Parasitemia; Anti-malarial Treatment + Rabies Vaccine159
Overall StudyReceived Study VaccinationGroup 5: No Parasitemia, Anti-malarial Prophylaxis + Rabies Vaccine127
Overall StudyCOMPLETEDGroup 1: Positive Parasitemia; Anti-malarial Treatment + RTS,S/AS01E Vaccine136
Overall StudyCOMPLETEDGroup 2: No Parasitemia; Anti-malarial Prophylaxis + RTS,S/AS01E Vaccine108
Overall StudyCOMPLETEDGroup 3: Positive Parasitemia; RTS,S/AS01E Vaccine32
Overall StudyCOMPLETEDGroup 4: Positive Parasitemia; Anti-malarial Treatment + Rabies Vaccine148
Overall StudyCOMPLETEDGroup 5: No Parasitemia, Anti-malarial Prophylaxis + Rabies Vaccine115
Overall StudyNOT COMPLETEDGroup 1: Positive Parasitemia; Anti-malarial Treatment + RTS,S/AS01E Vaccine28
Overall StudyNOT COMPLETEDGroup 2: No Parasitemia; Anti-malarial Prophylaxis + RTS,S/AS01E Vaccine20
Overall StudyNOT COMPLETEDGroup 3: Positive Parasitemia; RTS,S/AS01E Vaccine4
Overall StudyNOT COMPLETEDGroup 4: Positive Parasitemia; Anti-malarial Treatment + Rabies Vaccine16
Overall StudyNOT COMPLETEDGroup 5: No Parasitemia, Anti-malarial Prophylaxis + Rabies Vaccine13

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04661579/flow

API referenceFor AI assistants